Efficacy of Autotransfusion in Hepatectomy for Hepatocellular Carcinoma
Jiro Fujimoto, MD;
Eizo Okamoto, MD;
Naoki Yamanaka, MD;
Takeshi Oriyama, MD;
Kazutaka Furukawa, MD;
Eisuke Kawamura, MD;
Tsuneo Tanaka, MD;
Fumihito Tomoda, MD
Arch Surg. 1993;128(9):1065-1069.
Abstract
| |
Purpose
Although autotransfusion is used in a wide variety of surgical procedures, it is largely unexplored for use in oncologic operations. This study evaluates the impact of autotransfusion in hepatectomy for hepatocellular carcinoma.
Patients and Methods
Fifty-four patients with hepatocellular carcinoma underwent hepatectomy by receiving autologous blood transfusion (group 1). Fifty patients receiving homologous blood without any autologous blood were matched for comparison (group 2).
Results
No statistical differences were found between group 1 and group 2 patients in cumulative recurrence rates (62.8% vs 67.3%, respectively) or cumulative survival rates (61.9% vs 52.8%). Autologous transfusion reduced the mean volume of homologous blood used (814 mL vs 3466 mL). The mean postoperative hemoglobin level, platelet count, prothrombin time, and partial thromboplastin time were comparable between groups.
Conclusions
Autotransfusion is a safe and effective procedure in patients with hepatocellular carcinoma undergoing hepatectomy.
(Arch Surg. 1993;128:1065-1069)
Author Affiliations
From The First Department of Surgery, Hyogo College of Medicine, Nishinomiya, Japan.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
The Impact of New Technology on Hepatic Resection for Malignancy
Papadimitriou et al.
Arch Surg 2001;136:1307-1313.
ABSTRACT
| FULL TEXT
|
